These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Treatment of cytomegalovirus retinitis with ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (BW B759U).
    Author: Orellana J, Teich SA, Winterkorn JS, Mathur-Wagh U, Handwerger S, Schlamm H, Malamud SC, Yancovitz SR, Cederberg DM, Mildvan DS.
    Journal: Br J Ophthalmol; 1988 Jul; 72(7):525-9. PubMed ID: 2843219.
    Abstract:
    Six patients (11 eyes) with virologically confirmed cytomegalovirus (CMV) retinitis involving the posterior pole of the eye were treated with a new drug, ganciclovir. Treatment with intravenous ganciclovir consistently halted progression of retinitis and produced improvement in measures of visual function. However, within three weeks after cessation of therapy renewed CMV activity and worsening of visual function were observed in most cases. Maintenance therapy with ganciclovir extended the period of remission from CMV retinitis.
    [Abstract] [Full Text] [Related] [New Search]